Literature DB >> 24670315

A Novel Method for Super-selective Coil Embolization Using an Extremely Soft Bare Coil through a Liquid Embolic Delivery Microcatheter.

Nobutaka Horie1, Kentaro Hayashi, Minoru Morikawa, Tsuyoshi Izumo, Izumi Nagata.   

Abstract

Endovascular coil embolization for intracranial aneurysms, arteriovenous malformations (AVMs), dural arteriovenous fistulas (AVFs), and hypervascular tumors are recognized as an effective adjunctive or curative treatment. In this setting, it is sometimes difficult to navigate a coil delivery microcatheter to the target point of a tiny, tortuous vessel. We herein present a case series of a novel method that enabled super-selective coil embolization using an extremely soft bare, electrodetachable coil (ED extrasoft(®) coil) through a liquid embolic delivery microcatheter (Marathon(®)). The Marathon(®) catheter was successfully placed at the target point of the tiny, tortuous vessel, and coil embolization was achieved in all 16 patients with 9 AVMs, 2 distal aneurysms, 2 AVFs, and 3 meningiomas. The primary ED extrasoft(®) coil and delivery wire have a very small radius, and the coil is rapidly detachable with an alarm notice from the generator even under Marathon(®) with one marker. We believe that this technique can provide safe and efficient embolization for selected patients.

Entities:  

Mesh:

Year:  2014        PMID: 24670315      PMCID: PMC4628195          DOI: 10.2176/nmc.tn.2013-0335

Source DB:  PubMed          Journal:  Neurol Med Chir (Tokyo)        ISSN: 0470-8105            Impact factor:   1.742


Introduction

Recent advances in endovascular coil embolization have expanded the indications for cerebrovascular diseases including intracranial aneurysms, arteriovenous malformations (AVMs), dural arteriovenous fistulas (AVFs), and hypervascular tumors. Although many embolic materials are currently available, including coils (fiber coils and detachable coils), particles [Polyvinyl alcohol, Gelfoam® (Pharmacia & Upjohn Co., Kalamazoo, Michigan, USA), and Embospheres® (Merit Medical Systems, Inc., South Jordan, Utah, USA)], and liquid embolics [Onyx® (eV3 Inc., Plymouth, Minnesota, USA) and n-butyl-cyanoacrylate (NBCA)],[1,2)] it is still important to navigate a microcatheter to the target point of the artery with no friction for safe and efficient embolization. Therefore, it is ideal to use a small, soft microcatheter with high flexibility, trackability, and crossability that advances distally and has the capacity for various embolic materials, especially in a lesion with a tiny, tortuous target vessel. We herein present a case series involving a novel method that enabled super-selective coil embolization using an extremely soft bare coil [electrodetachable (ED) extrasoft® coil; Kaneka, Kanagawa] through a liquid embolic delivery microcatheter (Marathon®; ev3 Inc.) and discuss its clinical implications.

Methods

Patient selection

From January 2010 to March 2013, 16 patients who underwent coil embolization using ED extrasoft® coils through a Marathon® catheter were retrospectively analyzed. This strategy was chosen when the target artery was tiny with marked narrowing or atortuous course, and when proximal feeder embolization was utilized to prevent migration of the liquid embolics into the venous system or normal branches in high-flow AVMs. This was also applied for hypervascular tumors with feeding arteries arising from the internal carotid artery or vertebrobasilar arteries.

Endovascular procedure

Coil embolization was usually performed under local anesthesia. All procedures were performed using a biplane C-arm angiographic system with 3D reconstruction. After placing the guide catheter, the patients were systemically heparinized, and activated clotting times were checked hourly. Using a triple coaxial technique, the Marathon® catheter was navigated into the lesion over a microguidewire. In some patients, a routine coil delivery microcatheter, which was larger than the Marathon® catheter, initially failed to be navigated to the target vessels. After successful deployment of the ED extrasoft® coils through the Marathon® catheter, an angiographic image was obtained to check coil placement before detachment. Additional ED extrasoft® coils were used until obliteration of the lesion was achieved. The patients with AVM or tumors were planned to undergo surgical removal 2 to 4 days later.

Results

Patient characteristics are summarized in Table 1. ED extrasoft® coils were successfully placed in 16 patients with 9 cerebral/spinal AVMs, 2 distal aneurysms, 2 AVFs, and 3 meningiomas. Secondary ED extrasoft® coils of various sizes (1.5–4 mm) and lengths (1–8 cm) were smoothly introduced through the Marathon® catheter, and super-selective embolization was achieved. An ED Inifini extrasoft® coil (Kaneka, Kanagawa), which had a large loop design with a longer length, was also successfully applied in a patient with a distal anterior inferior cerebellar artery aneurysm (Case 10). In the selected case, NBCA was applied combined with an ED extrasoft® coil through the same Marathon® catheter (Cases 4–8, 10, and 13). Surgical removal was applied in all cerebral AVMs (Cases 1–8) and meningiomas (Cases 14–16), and successful removal of the lesion was achieved without any complications.
Table 1

Characteristics of 16 patients who underwent super-selective coil embolization using an ED extrasoft® coil through a Marathon® catheter

Case No.Age, SexDiseaseLocationTarget vesselED extrasoft® (diameter mm/length cm)Combined with NBCAObliterationSurgical RemovalGOS at discharge
1.31MCerebral AVM (ruptured)FrontalMCA3/3, 2.5/3, 2/6, 2/4NoNidus occlusionYesMD
2.17FCerebral AVM (ruptured)TemporalMCA2/4, 2/3NoFeeder occlusionYesMD
3.16MCerebral AVM (ruptured)FrontalACA2/6, 2/4, 1.5/3NoFeeder occlusionYesGR
4.30MCerebral AVM (ruptured)Parieto-occipitalMCA3/6, 2.5/6, 2/6YesFeeder occlusionYesMD
5.58MCerebral AVM (ruptured)CerebellumPICA1.5/3YesFeeder occlusionYesMD
6.53MCerebral AVM (ruptured)CerebellumSCA4/8, 3.5/8, 2.5/4, 2/4YesFeeder occlusionYesMD
7.67MCerebral AVM (ruptured)Parieto-occipitalMCA3.5/8, 3/8, 2.5/8, 2/8YesFeeder occlusionYesMD
8.48FCerebral AVM (ruptured)FrontalMCA3/6, 3/4YesFeeder occlusionYesGR
9.57MSpinal AVMC5Radiculomedullary A1.5/1NoFeeder occlusionNoGR
10.31FDistal AICA ANAICAAICA*16/15, *16/10, 1.5/2YesAneurysm obliterationNoMD
11.61FDistal MCA AN (ruptured)MCAMCA2.5/6, 1.5/3NoAneurysm obliterationNoGR
12.62MDural AVFAnterior fossaOphthalmic A1.5/2NoFeeder occlusionNoGR
13.74FDural AVFCavernous sinusMMA, Aph A2/6, 2/4, 1.5/3YesFeeder occlusionNoGR
14.78MMeningiomaOccipitalMCA2.5/6, 2/6, 2/3, 1.5/3NoFeeder occlusionYesGR
15.55MMeningiomaCerebellumPICA2/6, 2/4NoFeeder occlusionYesGR
16.52FMeningiomaTemporalMHT1.5/1NoFeeder occlusionYesGR

ED Inifini extrasoft® coil. A: artery, ACA: anterior cerebral artery, AICA: anterior inferior cerebeller artery, AN: aneurysm, AphA: ascending pharyngeal artery, AVF: arteriovenous fistula, AVM: arteriovenous malformation, ED: electrodetachable, F: female, GOS: Glasgow Outcome Scale, GR: good recovery, M: male, MCA: middle cerebral artery, MD: moderate disability, MHT: meningohypophysial trunk, MMA: middle meningeal artery, PICA: posterior inferior cerebeller artery, SCA: superior cerebellar artery.

Illustrative Cases

Case 10

A 31-year-old female patient was found to have an irregular aneurysm at the distal part of the right anterior inferior cerebellar artery (AICA) during a brain check-up (Fig. 1A). A Marathon® catheter was navigated into the aneurysm, and aneurysm embolization was performed using ED Inifini extrasoft® (16 mm/15 cm, 16 mm/10 cm) and an ED extrasoft® coil (1.5 mm/2 cm), which resulted in body filling (Fig. 1B). Further embolization was undertaken using 33% NBCA through the same microcatheter, and complete obliteration of the aneurysm was achieved (Fig. 1C). Unfortunately, postoperative angiogram showed delayed appearance of distal AICA (Fig. 1C), and postoperative magnetic resonance (MR) imaging showed a fresh cerebellar infarction in the distal AICA territory. The patient complained right facial palsy (House-Brackmann grade 2), which gradually improved during the follow-up.
Fig. 1

A 31-year-old female patient with a distal aneurysm at the anterior inferior cerebellar artery (AICA) (Case 10). Anteroposterior right vertebral artery angiogram showing an aneurysm at the distalpart of the AICA (A). A Marathon® catheter was smoothly navigated into the aneurysm, and the aneurysm was embolized with an ED Inifini extrasoft® and ED extrasoft® coil (arrow in B) in combination with 33% NBCA (C), achieving complete obliteration of the aneurysm.

Case 12

A 62-year-old male patient presented with progressing headache for 1 month. Digital subtraction angiography revealed an anterior fossa AVF draining into the superior sagittal sinus (Fig. 2A, B). A coil delivery microcatheter was distally navigated to the ophthalmic artery, but failed because of tortuosity of the vessel. Next, a Marathon® catheter was smoothly navigated distally to the shunting point beyond the origin of the central retinal artery (Fig. 2C). An ED extrasoft® coil (1.5 mm/2 cm) was successfully detached to occlude the recurrent meningeal artery (Fig. 2D).
Fig. 2

A 62-year-old male patient with an anterior fossa arteriovenous fistula (AVF) draining into the superior sagittal sinus (Case 12). Left internal carotid angiogram showing a tortuous feeder from the ophthalmic artery (A: A-P view, B: lateral view). The coil delivery microcatheter failed to be navigated beyond the origin of the central retinal artery, and a Marathon® catheter was successfully navigated (arrow in C). After embolization of the artery with an ED extrasoft® coil, the feeder was completely obliterated (D).

Discussion

Recently, endovascular therapy has greatly enhanced the care of neurosurgical patients. Progress in technology and techniques continue to push forward the boundaries of what is deemed “treatable,” assuming acceptable risk. Numerous devices and embolic materials are currently available, and clinicians should be aware of the characteristics of each material.[1)] The choice of embolic materials depends on the occlusion point, vasculature, flow pattern of the target artery, and microcatheter size. Marathon® is a liquid embolic delivery catheter that is often used for AVM embolization in combination with the liquid agent NBCA[3,4)] or Onyx®.[5–7)] This microcatheter has a 1.5-F smaller distal tip (0.013 inch), which enables further navigation to the intracranial arteries. However, a liquid agent is uncontrollable, and it is sometimes difficult to obliterate an AVM with an aneurysm or a high-flow AVM. Moreover, liquid embolics have a risk of distal migration into the venous system or normal branches in such cases.[8–10)] To address these issues, detachable coils that can be delivered through the Marathon® catheter provide safe and efficient embolization for selected AVMs,[11)] as well as for distal aneurysms, AVFs, and hypervascular tumors with tortuous and narrow vessels. We herein report the successful demonstration of a valuable technique using ED extrasoft® coils through a flow-guided Marathon® microcatheter. Some soft detachable coils with a very small primary diameter, such as the ED extrasoft® (0.01 inch), Target-10 ultrasoft® (0.01 inch; Stryker, Osaka), Micrusphere-10® (0.0098 inch; J&J Codman, San Jose, California, USA), Complex-10 soft® (0.0095 inch; Microvention, TERUMO, Tokyo), and Axium (0.0115 inch, Covidien, eV3, Tokyo) could be size-compatible with Marathon®. However, only the ED extrasoft® is available for Marathon® because this microcatheter has one marker that cannot be used for the delivery of detachable coils with the exception of the ED extrasoft®. The ED extrasoft® coil is a bare platinum coil with excellent handling properties attributable to the following features.[12)] First, the coil is extremely soft due to an unprecedentedly small diameter of the element wire and very flexible pusher wire system. Second, detachment of the coil is rapid and secure based on the ED system, with a polyvinyl alcohol rod at the junction of the platinum coil and delivery wire. In addition, it is easy to find the detachment point with an alarm notice from the generator. Therefore, it is not necessary to adjust the delivery wire to the second marker of the microcatheter in an ED extrasoft®. The ED extrasoft® also has the lowest profile (1.5 mm in diameter and 1 cm in length), which facilitates embolization of small lesions. With this technique, ED extrasoft ®coils and NBCA can be delivered from the same microcatheter in one session, if necessary. This could reduce the operating time and radiation dose, which is beneficial especially for complicated cases involving local anesthesia. Some pitfalls should be addressed in this technique. First, ED extrasoft® coil has a delivery wire with smaller diameter (0.012 inch) compared with other coils. Second, straightening phenomenon[13)] has been reported in ED extrasoft® coils due to coil folding. Therefore, ED extrasoft® coils with small diameter and shorter length might be better to stabilize the tip of Marathon® catheter. Advanced type of ED extrasoft® coils (type R) have 0.014 inch diameter delivery wire and longer pusher wire (180→187 cm), which improved pushability of coils. ED extrasoft® coils (type R) will figure out these technical pitfalls above and therefore could be a good candidate for the delivery through Marathon®.

Conclusion

Super-selective coil embolization using extremely soft bare coils (ED extrasoft® coils) through a liquid embolic delivery microcatheter provides safe and efficient obliteration of the feeding arteries in AVMs, AVFs, hypervascular tumors, and distal aneurysms. This method is very useful for feeder embolization in selected cases.
  13 in total

1.  Selective coil embolization through flow-directed microcatheter for intracranial arteriovenous malformations.

Authors:  Nobutaka Horie; Kentaro Hayashi; Minoru Morikawa; Izumi Nagata
Journal:  Acta Neurochir (Wien)       Date:  2012-02-24       Impact factor: 2.216

2.  The mechanism of catheter kickback in the final stage of coil embolization for aneurysms: the straightening phenomenon.

Authors:  S Miyachi; T Izumi; N Matsubara; T Naito; K-I Haraguchi; T Wakabayashi
Journal:  Interv Neuroradiol       Date:  2010-12-17       Impact factor: 1.610

3.  Outcome analysis of preoperative embolization with N-butyl cyanoacrylate in cerebral arteriovenous malformations.

Authors:  J S DeMeritt; J Pile-Spellman; H Mast; N Moohan; D C Lu; W L Young; L Hacein-Bey; J P Mohr; B M Stein
Journal:  AJNR Am J Neuroradiol       Date:  1995-10       Impact factor: 3.825

Review 4.  The role of neuroendovascular therapy for the treatment of brain arteriovenous malformations.

Authors:  David Fiorella; Felipe C Albuquerque; Henry H Woo; Cameron G McDougall; Peter A Rasmussen
Journal:  Neurosurgery       Date:  2006-11       Impact factor: 4.654

5.  Intracranial head and neck tumors: endovascular considerations, present and future.

Authors:  Rishi Gupta; Ajith J Thomas; Michael Horowitz
Journal:  Neurosurgery       Date:  2006-11       Impact factor: 4.654

6.  Preoperative embolization of intracranial arteriovenous malformations with Onyx.

Authors:  Werner Weber; Bernhard Kis; Ralf Siekmann; Paul Jans; Rudolf Laumer; Dietmar Kühne
Journal:  Neurosurgery       Date:  2007-08       Impact factor: 4.654

7.  Severe pulmonary oedema following therapeutic embolization with Onyx for cerebral arteriovenous malformation.

Authors:  C Murugesan; Sundararaj Saravanan; John Rajkumar; Jagadish Prasad; Sanjay Banakal; Kanchi Muralidhar
Journal:  Neuroradiology       Date:  2008-05       Impact factor: 2.804

8.  Embolization of intracranial arteriovenous malformations with ethylene-vinyl alcohol copolymer (Onyx).

Authors:  V Panagiotopoulos; E Gizewski; S Asgari; J Regel; M Forsting; I Wanke
Journal:  AJNR Am J Neuroradiol       Date:  2008-10-08       Impact factor: 3.825

9.  Comparison of N-butyl cyanoacrylate and onyx for the embolization of intracranial arteriovenous malformations: analysis of fluoroscopy and procedure times.

Authors:  Gregory J Velat; John F Reavey-Cantwell; Christopher Sistrom; David Smullen; Gregory L Fautheree; Jobyna Whiting; Stephen B Lewis; Robert A Mericle; Christopher S Firment; Brian L Hoh
Journal:  Neurosurgery       Date:  2008-07       Impact factor: 4.654

10.  Initial experience with an extremely soft bare platinum coil, ED coil-10 Extra Soft, for endovascular treatment of cerebral aneurysms.

Authors:  Kei Harada; Jun Morioka
Journal:  J Neurointerv Surg       Date:  2012-11-28       Impact factor: 5.836

View more
  6 in total

1.  Embolization of a peripheral cerebral aneurysm associated with intracranial major artery occlusion through a transdural anastomotic artery: Case report.

Authors:  Norito Fukuda; Kazuya Kanemaru; Koji Hashimoto; Hideyuki Yoshioka; Nobuo Senbokuya; Takashi Yagi; Hiroyuki Kinouchi
Journal:  Interv Neuroradiol       Date:  2018-09-19       Impact factor: 1.610

2.  Coil embolization through the Marathon microcatheter: Advantages and pitfalls.

Authors:  Joel S Beckett; Gary R Duckwiler; Satoshi Tateshima; Viktor Szeder; Reza Jahan; Nestor Gonzalez; Fernando Vinuela
Journal:  Interv Neuroradiol       Date:  2016-10-27       Impact factor: 1.610

3.  Coil Embolization of Unruptured Distal Anterior Cerebral Artery Aneurysm Using a Marathon Microcatheter.

Authors:  Kenji Fukutome; Hiroyuki Ohnishi; Yoshihiro Kuga; Hideyuki Ohnishi
Journal:  Cureus       Date:  2022-05-09

4.  High-Grade Dural Arteriovenous Fistulas : Use of Kaneka ED Coils with the Marathon Microcatheter for Transvenous Coil Embolization.

Authors:  P Bhogal; M AlMatter; V Hellstern; H Bäzner; O Ganslandt; H Henkes; M Aguilar Pérez
Journal:  Clin Neuroradiol       Date:  2018-08-30       Impact factor: 3.649

5.  Use of Detachable Coils Without the Need of a Double Marker Microcatheter: Technical Note.

Authors:  Akiyo Sadato; Motoharu Hayakawa; Kazuhide Adachi; Yoko Kato; Yuichi Hirose
Journal:  Asian J Neurosurg       Date:  2018 Jan-Mar

6.  Effectiveness of Super-selective Embolization for Parasagittal Meningiomas and Its Effect on the Level of Inflammatory Factors.

Authors:  Zhaoke Zheng; Linwei Jia; Peihua Zhang; Yaohui Tian; Xi Chen
Journal:  Evid Based Complement Alternat Med       Date:  2022-08-01       Impact factor: 2.650

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.